Evidence map›Paper›PMID 18769450›Full record

ArticleLeukemia2008

Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4+ T cells.

M L Lesniewski, P Haviernik, R P Weitzel, S Kadereit, M M Kozik, L R Fanning, Y C Yang, Y Hegerfeldt, M R Finney, M Z Ratajczak and 4 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00003335 (A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Patients With High Risk Hematologic Malignancies), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00003335 phase2completednot on this map

A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Patients With High Risk Hematologic Malignancies

TypeinterventionalSponsorCase Comprehensive Cancer CenterRan1998 to 2012Enrolled44ConditionsGraft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic SyndromesArmsanti-thymocyte globulin, busulfan, cyclosporine, melphalan, methylprednisolone
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

M L LesniewskiDepartment of Medicine, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106-7284, USA.
P Haviernik
R P Weitzel
S Kadereit
M M Kozik
L R Fanning
Y C Yang
Y Hegerfeldt
M R Finney
M Z Ratajczak
N Greco
P Paul
J Maciejewski
M J Laughlin
Case Western Reserve University · USCleveland Cord Blood Center · USCase Comprehensive Cancer CenterCleveland Clinic · USUniversity of Konstanz · DEUniversity of Louisville · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
RESEARCH ONCOLOGY TRAINING GRANTT32CA059366 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JACKSON, MARK W. · 1993 to 2025
$5.5M
MECHANISMS UNDERLYING GRAFT-VERSUS-HOST DISEASER01AI047289 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LAUGHLIN, MARY J · 2000 to 2004
$1.3M
NCI NIH HHS 5P30CA043703NCI NIH HHS 5T32 CA059366-13NIAID NIH HHS R01-AI47289-01
6 · The paper itself

Abstract

On activation, umbilical cord blood (UCB) CD4(+) T cells demonstrate reduced expression of tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma), whereas maintaining equivalent interleukin-2 (IL-2) levels, as compared with adult peripheral blood (PB) CD4(+) T cells. Nuclear factor of activated T cells (NFAT1) protein, a transcription factor known to regulate the expression of IL-2, TNF-alpha and IFN-gamma, is reduced in resting and activated UCB CD4(+) T cells. In contrast, expression of Broad-complex-Tramtrack-Bric-a-Brac and Cap'n'collar homology 1 bZip transcription factor 2 (BACH2) was shown by gene array analyses to be increased in UCB CD4(+) T cells and was validated by qRT-PCR. Using chromatin immunoprecipitation, BACH2 was shown binding to the human IL-2 proximal promoter. Knockdown experiments of BACH2 by transient transfection of UCB CD4(+) T cells with BACH2 siRNA resulted in significant reductions in stimulated IL-2 production. Decreased IL-2 gene transcription in UCB CD4(+) T cells transfected with BACH2 siRNA was confirmed by a human IL-2 luciferase assay. In summary, BACH2 maintains IL-2 expression in UCB CD4(+) T cells at levels equivalent to adult PB CD4(+) T cells despite reduced NFAT1 protein expression. Thus, BACH2 expression is necessary to maintain IL-2 production when NFAT1 protein is reduced, potentially impacting UCB graft CD4(+) T-cell allogeneic responses.

Indexed as

Base SequenceBasic-Leucine Zipper Transcription FactorsCD4-Positive T-LymphocytesCell Line, TumorFetal BloodGene ExpressionGenes, ReporterHumansImmune ToleranceInterleukin-2NFATC Transcription FactorsPromoter Regions, GeneticRNA, MessengerRNA, Small InterferingTh1 CellsTransfectionBACH2 protein, humanBasic-Leucine Zipper Transcription FactorsInterleukin-2NFATC2 protein, humanNFATC Transcription FactorsRNA, MessengerRNA, Small Interfering

Identifiers

PMID18769450
OpenAlexW2161923506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.